⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Baroda BNP Paribas Value Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Baroda BNP Paribas | HDFC MF |
| Category | Equity - Value Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹13.49 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Rohan Korde | Nikhil Mathur |
| Inception | 07 Jun 2023 | 04 Oct 2023 |
| Returns | ||
| 1Y | -7.13% | 22.64% |
| 3Y | 8.75% | 30.41% |
| 5Y | — | — |
| Since Inception | 9.21% | 29.15% |
| Risk | ||
| 13.57 | 14.07 | |
| 0.93 | 0.59 | |
| 0.19 | 1.59 | |
| -0.98 | 21.67 | |
| 0.36 | 3.48 | |
| -10.71% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.33% | 1.03% |
| Exit Load | Nil upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Baroda BNP Pa…91%
HDFC MF91%
9.3%Only 9.3% of holdings by weight are common between Baroda BNP Paribas and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingBaroda BNP ParibasHDFC MF
Divi's Laboratories Ltd.4.04%9.39%
Sun Pharmaceutical Industries Ltd.2.67%8.28%
Torrent Pharmaceuticals Ltd.2.63%3.65%
Category context: Equity vs Equity. Open the full Screener →